- Title
- LBO04 - Safety and efficacy of combination therapies including cilofexor/ firsocostat in patients with bridging fibrosis and cirrhosis due to NASH: Results of the phase 2b ATLAS trial
- Creators
- Rohit LoombaMazen NoureddinKris KowdleyAnita KohliAasim SheikhGuy NeffBal Raj BhandariNadege T. GunnStephen CaldwellZachary GoodmanIlan WapinskiMurray ResnickAndrew BeckDora DingCatherine JiaRyan HussChuhan ChungMani SubramanianRobert MyersKeyur PatelBrian BorgReem GhalibHeidi KablerJohn PoulosZiad H. YounesMagdy ElkhashabTarek HassaneinRajalakshmi IyerPeter RuaneMitchell ShiffmanSimone StrasserVincent Wai-Sun WongNaim Alkhouri
- Publication Details
- Journal of hepatology, Vol.73, pp.S116-S117
- Publisher
- Elsevier B.V
- Identifiers
- 991005968895202656
- Academic Unit
- Internal Medicine
- Language
- English
- Resource Type
- Journal article
Journal article
LBO04 - Safety and efficacy of combination therapies including cilofexor/ firsocostat in patients with bridging fibrosis and cirrhosis due to NASH: Results of the phase 2b ATLAS trial
Journal of hepatology, Vol.73, pp.S116-S117
08/2020
Metrics
4 Record Views